November 8, 2023 — Agamon Health is a healthcare technology company that uses Generative AI and workflow automation to close gaps in patient care.

November 8, 2023 — The combination of persistent tobacco use and prediabetes (higher than normal blood sugar levels that may progress to Type 2 diabetes) triples the risk of 

November 8, 2023 — AIBODY, a leader in digital physiology solutions for healthcare, recently announced the release of Nova Heart, its first commercial product developed in collaboration with the 

November 7, 2023 — The U.S. Food and Drug Administration (FDA) announced that Teleflex, and its subsidiary Arrow International, are recalling the Pressure Injectable Catheter Kits due to mislabeling regarding the presence of chlorhexidine in these products.

November 7, 2023 — Shockwave Medical, Inc, a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, announced today that as part of the 

Here's a look at what viewers found most interesting during the month of October on dicardiology.com

As another month comes to a close, DAIC takes a look at the Top 10 most-read pieces of content from www.dicardiology.com during the month of October. 

1. Joint Statement on Aortic Valve Replacement in Low-Risk Patients Issued by Society of Thoracic Surgeons and European Association for Cardiothoracic Surgeons

November 6, 2023 — Advances in artificial intelligence have enabled the development and application of AI tools that may be effective at detecting heart valvular disease and predicting the risk of cardiovascular disease events, according to preliminary research in two studies to be presented at the American Heart Association’s 

November 6, 2023 —  Bristol Myers Squibb  announced that research across the company’s cardiovascular franchise will be pres

November 6, 2023 — Atrial fibrillation (AF) diagnosis was associated with a 45% increased risk of mild cognitive impairment (MCI) among a cohort of 4.3 million individuals in the UK, according to a new study published in JACC: Advances. These findings suggest that cardiovascular risk factors and multiple comorbidities could further the progression from MCI to dementia in this cohort. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now